182 related articles for article (PubMed ID: 36651627)
1. Effectiveness of direct-acting antiviral therapy among Aboriginal and Torres Strait Islander peoples with HCV infection in Australia: A national real-world cohort (REACH-C).
Hudson-Buhagiar J; Carson J; Monaghan S; Collie P; Nelson R; Van Gessel H; Read P; Hanson J; Monaghan R; Matthews G; Dore GJ; Martinello M;
J Viral Hepat; 2023 May; 30(5):386-396. PubMed ID: 36651627
[TBL] [Abstract][Full Text] [Related]
2. Evaluating the prevalence of current hepatitis C infection and treatment among Aboriginal and Torres Strait Islander peoples who inject drugs in Australia: The ETHOS engage study.
Hobday S; Valerio H; Combo T; Monaghan R; Scott C; Silk D; Murray C; Read P; Henderson C; Degenhardt L; Treloar C; Dore GJ; Grebely J; Martinello M;
Drug Alcohol Rev; 2023 Nov; 42(7):1617-1632. PubMed ID: 37556376
[TBL] [Abstract][Full Text] [Related]
3. Barriers and Facilitators to Hepatitis C Virus (HCV) Treatment for Aboriginal and Torres Strait Islander Peoples in Rural South Australia: A Service Providers' Perspective.
Lim D; Phillips E; Bradley C; Ward J
Int J Environ Res Public Health; 2023 Mar; 20(5):. PubMed ID: 36901423
[TBL] [Abstract][Full Text] [Related]
4. High Effectiveness of Broad Access Direct-Acting Antiviral Therapy for Hepatitis C in an Australian Real-World Cohort: The REACH-C Study.
Yee J; Carson JM; Hajarizadeh B; Hanson J; O'Beirne J; Iser D; Read P; Balcomb A; Doyle JS; Davies J; Martinello M; Marks P; Dore GJ; Matthews GV;
Hepatol Commun; 2022 Mar; 6(3):496-512. PubMed ID: 34729957
[TBL] [Abstract][Full Text] [Related]
5. Optimising Hepatitis C care in an urban Aboriginal and Torres Strait Islander primary health care clinic.
Lakhan P; Askew D; Hayman N; Pokino LA; Sendall C; Clark PJ
Aust N Z J Public Health; 2019 Jun; 43(3):228-235. PubMed ID: 30908846
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis C treatment outcomes for Australian First Nations Peoples: equivalent SVR rate but higher rates of loss to follow-up.
Clark PJ; Valery PC; Ward J; Strasser SI; Weltman M; Thompson A; Levy MT; Leggett B; Zekry A; Rong J; Angus P; George J; Bollipo S; McGarity B; Sievert W; Macquillan G; Tse E; Nicoll A; Wade A; Chu G; Harding D; Cheng W; Farrell G; Roberts SK
BMC Gastroenterol; 2022 Jul; 22(1):339. PubMed ID: 35820850
[TBL] [Abstract][Full Text] [Related]
7. Delivering direct acting antiviral therapy for hepatitis C to highly marginalised and current drug injecting populations in a targeted primary health care setting.
Read P; Lothian R; Chronister K; Gilliver R; Kearley J; Dore GJ; van Beek I
Int J Drug Policy; 2017 Sep; 47():209-215. PubMed ID: 28587943
[TBL] [Abstract][Full Text] [Related]
8. The potential for tailored screening to reduce bowel cancer mortality for Aboriginal and Torres Strait Islander peoples in Australia: Modelling study.
Lew JB; Feletto E; Worthington J; Roder D; Canuto K; Miller C; D'Onise K; Canfell K
J Cancer Policy; 2022 Jun; 32():100325. PubMed ID: 35560263
[TBL] [Abstract][Full Text] [Related]
9. Release of the National Scheme's Aboriginal and Torres Strait Islander Health and Cultural Safety Strategy 2020-2025; the impacts for podiatry in Australia: a commentary.
Gerrard JM; Godwin S; Chuter V; Munteanu SE; West M; Hawke F
J Foot Ankle Res; 2021 May; 14(1):38. PubMed ID: 33971934
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis C care cascade before and during the direct-acting antiviral eras in New South Wales, Australia: A population-based linkage study.
Yousafzai MT; Alavi M; Valerio H; Hajarizadeh B; Grebely J; Dore GJ
J Viral Hepat; 2023 Mar; 30(3):250-261. PubMed ID: 36537024
[TBL] [Abstract][Full Text] [Related]
11. Partnering with Aboriginal and Torres Strait Islander Peoples: An Evaluation Study Protocol to Strengthen a Comprehensive Multi-Scale Evaluation Framework for Participatory Systems Modelling through Indigenous Paradigms and Methodologies.
Lee GY; Robotham J; Song YJC; Occhipinti JA; Troy J; Hirvonen T; Feirer D; Iannelli O; Loblay V; Freebairn L; Agung-Igusti R; Chang EP; Dudgeon P; Hickie IB
Int J Environ Res Public Health; 2022 Dec; 20(1):. PubMed ID: 36612375
[TBL] [Abstract][Full Text] [Related]
12. Moving Towards Hepatitis C Microelimination Among People Living With Human Immunodeficiency Virus in Australia: The CEASE Study.
Martinello M; Yee J; Bartlett SR; Read P; Baker D; Post JJ; Finlayson R; Bloch M; Doyle J; Shaw D; Hellard M; Petoumenos K; Lin L; Marks P; Applegate T; Dore GJ; Matthews GV
Clin Infect Dis; 2020 Sep; 71(6):1502-1510. PubMed ID: 31585005
[TBL] [Abstract][Full Text] [Related]
13. Liver Disease and Poor Adherence Limit Hepatitis C Cure: A Real-World Australian Treatment Cohort.
Clark PJ; Valery PC; Strasser SI; Weltman M; Thompson AJ; Levy M; Leggett B; Zekry A; Rong J; Angus P; George J; Bollipo S; McGarity B; Sievert W; Macquillan G; Tse E; Nicoll A; Wade A; Chu G; Harding D; Cheng W; Farrell G; Roberts SK
Dig Dis Sci; 2023 Jan; 68(1):291-303. PubMed ID: 35552941
[TBL] [Abstract][Full Text] [Related]
14. Direct-acting antiviral treatment of chronic HCV-infected patients on opioid substitution therapy: Still a concern in clinical practice?
Christensen S; Buggisch P; Mauss S; Böker KHW; Schott E; Klinker H; Zimmermann T; Weber B; Reimer J; Serfert Y; Wedemeyer H
Addiction; 2018 May; 113(5):868-882. PubMed ID: 29359361
[TBL] [Abstract][Full Text] [Related]
15. Vaccine preventable diseases and vaccination coverage in Aboriginal and Torres Strait Islander people, Australia 2003 to 2006.
Menzies R; Turnour C; Chiu C; McIntyre P
Commun Dis Intell Q Rep; 2008 Jun; 32 Suppl():S2-67. PubMed ID: 18711998
[TBL] [Abstract][Full Text] [Related]
16. Patient and healthcare provider perceptions of acceptability of fingerstick point-of-care hepatitis C testing at Aboriginal Community Controlled Health Services in Australia.
Lafferty L; Beadman M; Ward J; Flynn E; Hosseini-Hooshyar S; Martinello M; Treloar C
Int J Drug Policy; 2024 Mar; 125():104335. PubMed ID: 38342050
[TBL] [Abstract][Full Text] [Related]
17. Evaluating a complex health promotion program to reduce hepatitis C among Aboriginal and Torres Strait Islander peoples in New South Wales, Australia: the Deadly Liver Mob.
Treloar C; Beadman K; Beadman M; Smith KA; Christian J; Jackson AC; Tyson B; Anderson C; Smyth L; Walker M; Heslop J; Gahan G; Tawil V; Sheaves F; Maher L; Page J; Tilley D; Ryan A; Grant K; Donovan B; Stevens A; Slattery T; Pearce K; John-Leader F; Walden A; Lenton J; Crowley M; Cama E
Harm Reduct J; 2023 Oct; 20(1):153. PubMed ID: 37864234
[TBL] [Abstract][Full Text] [Related]
18. Effectiveness of treatment for hepatitis C virus reinfection following direct acting antiviral therapy in the REACH-C cohort.
Carson JM; Hajarizadeh B; Hanson J; O'Beirne J; Iser D; Read P; Balcomb A; Davies J; Doyle JS; Yee J; Martinello M; Marks P; Dore GJ; Matthews GV;
Int J Drug Policy; 2021 Oct; 96():103422. PubMed ID: 34426040
[TBL] [Abstract][Full Text] [Related]
19. Achieving cultural safety for Australia's First Peoples: a review of the Australian Health Practitioner Regulation Agency-registered health practitioners' Codes of Conduct and Codes of Ethics.
Milligan E; West R; Saunders V; Bialocerkowski A; Creedy D; Rowe Minniss F; Hall K; Vervoort S
Aust Health Rev; 2021 Aug; 45(4):398-406. PubMed ID: 33844959
[TBL] [Abstract][Full Text] [Related]
20. Assessing the quality of health research from an Indigenous perspective: the Aboriginal and Torres Strait Islander quality appraisal tool.
Harfield S; Pearson O; Morey K; Kite E; Canuto K; Glover K; Gomersall JS; Carter D; Davy C; Aromataris E; Braunack-Mayer A
BMC Med Res Methodol; 2020 Apr; 20(1):79. PubMed ID: 32276606
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
